Skip navigation Wisconsin State Legislature
This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Report received from Agency, January 3, 2023.
To committee on Veterans and Military Affairs.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-026
Relating to long-term care services and Medical Assistance fair hearing process.
Submitted by Department of Health Services.
Report received from Agency, January 3, 2023.
To committee on Health, Aging and Long-Term Care.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-027
Relating to licensure requirements.
Submitted by Occupational Therapists Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
To committee on Workforce Development and Economic Opportunities.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-028
Relating to continuing education.
Submitted by Occupational Therapists Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
To committee on Workforce Development and Economic Opportunities.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-032
Relating to scheduling Serdexmethylphenidate.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-033
Relating to scheduling ten (10) fentanyl related substances.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-034
Relating to scheduling Alfaxalone.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-035
Relating to Excluding 6-beta-Naltrexol.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-036
Relating to scheduling Fospropofol.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-037
Relating to scheduling Embutramide.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-038
Relating to scheduling Perampanel.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-039
Relating to scheduling Lacosamide.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-040
Relating to transferring 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP.
Submitted by Controlled Substances Board.
Report received from Agency, January 3, 2023.
To committee on Criminal Justice and Public Safety.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-041
Relating to general updates.
Submitted by Department of Veterans Affairs.
Report received from Agency, January 3, 2023.
To committee on Veterans and Military Affairs.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-042
Relating to the employment and entrepreneurship grants transition program.
Submitted by Department of Veterans Affairs.
Report received from Agency, January 3, 2023.
To committee on Veterans and Military Affairs.
Referred on January 12, 2023.
Assembly Clearinghouse Rule 22-043
Relating to telehealth.
Loading...
Loading...